NASDAQ:ACHV Achieve Life Sciences (ACHV) Stock Price, News & Analysis $4.16 0.00 (0.00%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$4.10▼$4.2550-Day Range$4.16▼$5.1452-Week Range$3.03▼$5.98Volume57,117 shsAverage Volume92,471 shsMarket Capitalization$143.03 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Achieve Life Sciences alerts: Email Address Achieve Life Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside236.1% Upside$14.00 Price TargetShort InterestBearish8.68% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.65Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($1.01) to ($1.09) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.59 out of 5 starsMedical Sector841st out of 910 stocksDiagnostic Substances Industry12th out of 14 stocks 3.5 Analyst's Opinion Consensus RatingAchieve Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAchieve Life Sciences has only been the subject of 1 research reports in the past 90 days.Read more about Achieve Life Sciences' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted8.68% of the outstanding shares of Achieve Life Sciences have been sold short.Short Interest Ratio / Days to CoverAchieve Life Sciences has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.Change versus previous monthShort interest in Achieve Life Sciences has recently increased by 9.56%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAchieve Life Sciences does not currently pay a dividend.Dividend GrowthAchieve Life Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ACHV. Previous Next 2.6 News and Social Media Coverage News SentimentAchieve Life Sciences has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Achieve Life Sciences this week, compared to 2 articles on an average week.Search Interest4 people have searched for ACHV on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Achieve Life Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.00% of the stock of Achieve Life Sciences is held by insiders.Percentage Held by InstitutionsOnly 33.52% of the stock of Achieve Life Sciences is held by institutions.Read more about Achieve Life Sciences' insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Achieve Life Sciences are expected to decrease in the coming year, from ($1.01) to ($1.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Achieve Life Sciences is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Achieve Life Sciences is -3.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAchieve Life Sciences has a P/B Ratio of 3.39. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Achieve Life Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade About Achieve Life Sciences Stock (NASDAQ:ACHV)Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.Read More ACHV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACHV Stock News HeadlinesSeptember 5 at 9:00 AM | villagegreennj.comAchieve Foundation Announces 22nd Annual Newstead 5K Fundraiser on September 21September 4 at 5:22 PM | finance.yahoo.comACHV: New Skipper at the HelmSeptember 7, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… September 3, 2024 | americanbankingnews.comAchieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest UpdateAugust 31, 2024 | sg.finance.yahoo.comAchieve Life Sciences Inc (SP4P.MU)August 28, 2024 | marketwatch.comAchieve Life Sciences Says Richard Stewart Reassumes CEO RoleAugust 28, 2024 | markets.businessinsider.comBuy Rating for Achieve Life Sciences: Strategic Growth and Solid Financials Amidst Leadership TransitionAugust 28, 2024 | markets.businessinsider.comLake Street Sticks to Its Buy Rating for Achieve Life Sciences (ACHV)September 7, 2024 | Paradigm Press (Ad)Kamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move… August 26, 2024 | globenewswire.comAchieve Life Sciences Announces Changes in Executive Leadership and Board of DirectorsAugust 17, 2024 | msn.comOpen for Business: Achieve Health NV offers primary care and weight management servicesAugust 16, 2024 | markets.businessinsider.comAchieve Life Sciences: Buy Rating on Strong Financials and Promising Cytisinicline ProspectsAugust 14, 2024 | yahoo.comCamp Kelly: Camp AchieveAugust 14, 2024 | seekingalpha.comAchieve Life Sciences, Inc. (ACHV) Q2 2024 Earnings Call TranscriptAugust 13, 2024 | msn.comACHV Stock Earnings: Achieve Life Sciences Misses EPS for Q2 2024August 13, 2024 | globenewswire.comAchieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate UpdateAugust 1, 2024 | markets.businessinsider.comBuy Rating for Achieve Life Sciences on Cytisinicline’s Promise in Nicotine Addiction TreatmentJuly 31, 2024 | uk.investing.comAchieve Life Sciences secures $20 million refinancingSee More Headlines Receive ACHV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achieve Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/07/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryBiotechnology Current SymbolNASDAQ:ACHV CUSIP68230A10 CIK949858 Webachievelifesciences.com Phone(604) 210-2217Fax425-686-1600Employees20Year FoundedN/APrice Target and Rating Average Stock Price Target$14.00 High Stock Price Target$20.00 Low Stock Price Target$11.00 Potential Upside/Downside+236.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,820,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-116.78% Return on Assets-61.70% Debt Debt-to-Equity Ratio0.21 Current Ratio4.56 Quick Ratio4.56 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-59.50Miscellaneous Outstanding Shares34,341,000Free Float33,654,000Market Cap$143.03 million OptionableOptionable Beta1.56 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Richard A. B. Stewart (Age 65)Executive Chairman Comp: $663.75kMr. John A. Bencich M.B.A. (Age 47)CEO & Director Comp: $781.75kDr. Cindy Jacobs M.D. (Age 66)Ph.D., President, Chief Medical Officer & Director Comp: $652.74kMr. Jerry Wan (Age 42)Principal Accounting Officer Dr. Anthony Clarke Ph.D. (Age 68)Chief Scientific Officer Comp: $546kMs. Jaime XinosExecutive Vice President of CommercialMore ExecutivesKey CompetitorsLexicon PharmaceuticalsNASDAQ:LXRXEmergent BioSolutionsNYSE:EBSXOMANASDAQ:XOMAVanda PharmaceuticalsNASDAQ:VNDARigel PharmaceuticalsNASDAQ:RIGLView All CompetitorsInstitutional OwnershipCVI Holdings LLCSold 495,443 shares on 8/15/2024Ownership: 0.209%The Manufacturers Life Insurance Company Bought 14,641 shares on 8/15/2024Ownership: 0.043%Sofinnova Investments Inc.Sold 129,858 shares on 8/10/2024Ownership: 4.043%Renaissance Technologies LLCBought 14,360 shares on 8/9/2024Ownership: 0.073%Rhumbline AdvisersBought 41,818 shares on 8/1/2024Ownership: 0.122%View All Institutional Transactions ACHV Stock Analysis - Frequently Asked Questions How have ACHV shares performed this year? Achieve Life Sciences' stock was trading at $4.12 at the beginning of 2024. Since then, ACHV stock has increased by 1.1% and is now trading at $4.1650. View the best growth stocks for 2024 here. How were Achieve Life Sciences' earnings last quarter? Achieve Life Sciences, Inc. (NASDAQ:ACHV) posted its quarterly earnings data on Tuesday, August, 13th. The biopharmaceutical company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.22) by $0.03. When did Achieve Life Sciences' stock split? Shares of Achieve Life Sciences reverse split before market open on Friday, July 31st 2020. The 1-20 reverse split was announced on Thursday, July 30th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 30th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Achieve Life Sciences' major shareholders? Achieve Life Sciences' top institutional shareholders include Sofinnova Investments Inc. (4.04%), Bank of New York Mellon Corp (0.30%), CVI Holdings LLC (0.21%) and Rhumbline Advisers (0.12%). View institutional ownership trends. How do I buy shares of Achieve Life Sciences? Shares of ACHV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Achieve Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Achieve Life Sciences investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Bionano Genomics (BNGO), Novan (NOVN), Aeterna Zentaris (AEZS) and Zosano Pharma (ZSAN). This page (NASDAQ:ACHV) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achieve Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achieve Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.